S&P 500

5.346,99

-0,11%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Transition Therapeutics - Ordinary Shares (TTHI)
Transition Therapeutics - Ordinary Shares (TTHI) Notícias

TTHI

Transition Therapeutics - Ordinary Shares (TTHI)

Transition Therapeutics - Ordinary Shares

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:TTHI

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
11/10/2016	14:51	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
13/09/2016	18:16	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
13/09/2016	18:14	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
09/09/2016	15:04	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
31/08/2016	09:56	Edgar (US Regulatory)	(25-NSE)	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
31/08/2016	02:00	Business Wire	OPKO Health Completes Acquisition of Transition Therapeutics	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
26/08/2016	09:52	Business Wire	Transition Therapeutics Shareholders Approve Acquisition by OPKO Health	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
25/08/2016	19:46	PR Newswire (US)	Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Ar...	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
30/06/2016	03:00	Business Wire	OPKO Health to Acquire Transition Therapeutics	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
03/06/2016	07:01	PR Newswire (Canada)	Transition Therapeutics Receives Notification From NASDAQ	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
11/05/2016	17:01	PR Newswire (Canada)	Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial Results	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
09/05/2016	17:01	PR Newswire (Canada)	Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:3...	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
25/04/2016	17:01	PR Newswire (Canada)	Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
18/04/2016	07:01	PR Newswire (US)	Transition Therapeutics Provides Update on Type 2 Diabetes Drug Candidate TT401	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
01/03/2016	18:30	PR Newswire (Canada)	Transition Therapeutics to Present at the 36th Annual Cowen Healthcare Conference	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
11/02/2016	20:26	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
09/02/2016	19:32	PR Newswire (Canada)	Transition Therapeutics Announces Second Quarter Fiscal 2016 Financial Results	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
05/02/2016	16:01	PR Newswire (US)	Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at ...	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
01/02/2016	09:01	PR Newswire (Canada)	Transition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
06/01/2016	09:01	PR Newswire (Canada)	Transition Therapeutics Announces Annual General Meeting Voting Results	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
19/11/2015	14:45	PR Newswire (Canada)	Transition Therapeutics to Host Investor Day November 23 in New York	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
10/11/2015	19:01	PR Newswire (US)	Transition Therapeutics Announces First Quarter Fiscal 2016 Financial Results	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
02/11/2015	09:01	PR Newswire (US)	Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at ...	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
29/10/2015	18:01	PR Newswire (US)	Transition Therapeutics Announces Agreement for Phase 2 Study of TT701 Drug Candidate	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
28/10/2015	08:01	PR Newswire (US)	Transition Therapeutics Announces Presentation of ELND005 Phase 2/3 Clinical Study Results at Clinical Trials in Alzheimer's ...	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
15/10/2015	07:01	PR Newswire (US)	Transition Therapeutics Announces Results of Data Analysis from ELND005 Phase 2/3 Clinical Study in Agitation and Aggression ...	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
15/09/2015	17:32	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
15/09/2015	17:01	PR Newswire (Canada)	Transition Therapeutics Announces Fiscal 2015 Financial Results	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
14/09/2015	07:01	PR Newswire (Canada)	Transition Therapeutics to Hold Conference Call on Fiscal 2015 Financial Results on Tuesday, September 15th, at 4:30 P.M. EST	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares
10/08/2015	17:01	PR Newswire (Canada)	Transition Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference	NASDAQ:TTHI	Transition Therapeutics - Ordinary Shares